Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Biochemistry & Physiology: Open Access received 1579 citations as per Google Scholar report
Vikas Bhat
Deptartment of Medicine
University of California
USA
Dr. Vikas Bhat received his PhD degree in Biochemistry and Molecular Biology from University of Miami, Florida, USA. His thesis was mainly focused on understanding the mechanism of interaction and functional characterization of apoptotic repressor protein BclXL. He primarily devoted his study on finding the novel in-vitro properties associated with this protein which were previously not understood. Using a diverse array of biophysical methods (such as microcalorimetry, light scattering and optical spectroscopy including transient measurements) in conjunction with other in silico, protein biochemistry and molecular biology techniques to decipher the mechanism of action of the BclXL apoptotic repressor. In particular, his work has provided new insights into the ability of BclXL to assemble into highly-ordered amyloid-like fibrils with length in the order of mm and a diameter in the um-range under elevated temperatures. Strikingly, the BclXL fibrils appear to be optimally primed for insertion into cardiolipin bicelles, implying that they likely represent an on-pathway intermediate for insertion into mitochondrial outer membrane during the onset of apoptosis. During his PhD, he published many first author and coauthor papers focused around elucidating novel biophysical and biochemical properties of proteins involved in regulating many important pathways in a cell. Currently working at the University of California, San Diego as a post-doctoral scholar, Dr. Bhat is actively involved in finding novel protein based therapeutics for regulating blood loss in hemophilia and various other diseases related to coagulation pathway.
Proteomics, Structural Biochemistry, Molecular Biophysics, Cellular Signaling, Homeostasis and Drug Discovery
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals